Clinical Trial: Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781722) titled 'Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis' on Aug. 19.

Brief Summary: The goal of this clinical trial is to learn if a single intravenous dose of tacrolimus, given before an ERCP procedure (an endoscopic procedure of the bile ducts and pancreas), can prevent post-ERCP pancreatitis (PEP) in adults at moderate-to-high risk of developing this complication.

The main question it aims to answer is:

* Does a single dose of tacrolimus lower the number of participants who develop pancreatitis after ERCP?

Researchers will compare tacrolimus to a placebo (a look-alike solution with no active drug) to see if tacrolimus reduces the ...